Literature DB >> 21550978

N-linked glycosylation regulates human proteinase-activated receptor-1 cell surface expression and disarming via neutrophil proteinases and thermolysin.

Yu Pei Xiao1, Alyn H Morice, Steven J Compton, Laura Sadofsky.   

Abstract

Proteinase-activated receptor 1 (PAR(1)) induces activation of platelet and vascular cells after proteolytic cleavage of its extracellular N terminus by thrombin. In pathological situations, other proteinases may be generated in the circulation and might modify the responses of PAR(1) by cleaving extracellular domains. In this study, epitope-tagged wild-type human PAR(1) (hPAR(1)) and a panel of N-linked glycosylation-deficient mutant receptors were permanently expressed in epithelial cells (Kirsten murine sarcoma virus-transformed rat kidney cells and CHO cells). We have analyzed the role of N-linked glycosylation in regulating proteinase activation/disarming and cell global expression of hPAR(1). We reported for the first time that glycosylation in the N terminus of hPAR(1) downstream of the tethered ligand (especially Asn(75)) governs receptor disarming to trypsin, thermolysin, and the neutrophil proteinases elastase and proteinase 3 but not cathepsin G. In addition, hPAR(1) is heavily N-linked glycosylated and sialylated in epithelial cell lines, and glycosylation occurs at all five consensus sites, namely, Asn(35), Asn(62), Asn(75), Asn(250), and Asn(259). Removing these N-linked glycosylation sequons affected hPAR(1) cell surface expression to varying degrees, and N-linked glycosylation at extracellular loop 2 (especially Asn(250)) of hPAR(1) is essential for optimal receptor cell surface expression and receptor stability.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21550978      PMCID: PMC3123067          DOI: 10.1074/jbc.M110.204271

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

Review 1.  Proteinase-activated receptors.

Authors:  S R Macfarlane; M J Seatter; T Kanke; G D Hunter; R Plevin
Journal:  Pharmacol Rev       Date:  2001-06       Impact factor: 25.468

2.  Cathepsin G activates protease-activated receptor-4 in human platelets.

Authors:  G R Sambrano; W Huang; T Faruqi; S Mahrus; C Craik; S R Coughlin
Journal:  J Biol Chem       Date:  2000-03-10       Impact factor: 5.157

3.  Human bronchial epithelial cells express PAR-2 with different sensitivity to thermolysin.

Authors:  Joachim J Ubl; Zoryana V Grishina; Tatiana K Sukhomlin; Tobias Welte; Fariba Sedehizade; Georg Reiser
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-06       Impact factor: 5.464

4.  Specific inhibition of thrombin-induced cell activation by the neutrophil proteinases elastase, cathepsin G, and proteinase 3: evidence for distinct cleavage sites within the aminoterminal domain of the thrombin receptor.

Authors:  P Renesto; M Si-Tahar; M Moniatte; V Balloy; A Van Dorsselaer; D Pidard; M Chignard
Journal:  Blood       Date:  1997-03-15       Impact factor: 22.113

5.  Proteolysis of the exodomain of recombinant protease-activated receptors: prediction of receptor activation or inactivation by MALDI mass spectrometry.

Authors:  D Loew; C Perrault; M Morales; S Moog; C Ravanat; S Schuhler; R Arcone; C Pietropaolo; J P Cazenave; A van Dorsselaer; F Lanza
Journal:  Biochemistry       Date:  2000-09-05       Impact factor: 3.162

6.  Activation of human oral epithelial cells by neutrophil proteinase 3 through protease-activated receptor-2.

Authors:  Akiko Uehara; Shunji Sugawara; Koji Muramoto; Haruhiko Takada
Journal:  J Immunol       Date:  2002-10-15       Impact factor: 5.422

7.  Glycosylation and the activation of proteinase-activated receptor 2 (PAR(2)) by human mast cell tryptase.

Authors:  S J Compton; B Renaux; S J Wijesuriya; M D Hollenberg
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

8.  Glycosylation of human proteinase-activated receptor-2 (hPAR2): role in cell surface expression and signalling.

Authors:  Steven J Compton; Sabrina Sandhu; Suranga J Wijesuriya; Morley D Hollenberg
Journal:  Biochem J       Date:  2002-12-01       Impact factor: 3.857

9.  Tethered ligand-derived peptides of proteinase-activated receptor 3 (PAR3) activate PAR1 and PAR2 in Jurkat T cells.

Authors:  Kristina K Hansen; Mahmoud Saifeddine; Morley D Hollenberg
Journal:  Immunology       Date:  2004-06       Impact factor: 7.397

10.  Unproductive cleavage and the inactivation of protease-activated receptor-1 by trypsin in vascular endothelial cells.

Authors:  Tetsuzo Nakayama; Katsuya Hirano; Yoshinobu Shintani; Junji Nishimura; Akio Nakatsuka; Hirotaka Kuga; Shosuke Takahashi; Hideo Kanaide
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

View more
  5 in total

1.  The N-terminal region of the dopamine D2 receptor, a rhodopsin-like GPCR, regulates correct integration into the plasma membrane and endocytic routes.

Authors:  D I Cho; C Min; K S Jung; S Y Cheong; M Zheng; S J Cheong; M H Oak; J H Cheong; B K Lee; K M Kim
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 2.  G Protein-Coupled Receptors in the Sweet Spot: Glycosylation and other Post-translational Modifications.

Authors:  Christoffer K Goth; Ulla E Petäjä-Repo; Mette M Rosenkilde
Journal:  ACS Pharmacol Transl Sci       Date:  2020-03-17

3.  The atypical N-glycosylation motif, Asn-Cys-Cys, in human GPR109A is required for normal cell surface expression and intracellular signaling.

Authors:  Daisuke Yasuda; Yuki Imura; Satoshi Ishii; Takao Shimizu; Motonao Nakamura
Journal:  FASEB J       Date:  2015-02-17       Impact factor: 5.191

4.  PAR-1 is a novel mechano-sensor transducing laminar flow-mediated endothelial signaling.

Authors:  Suji Kim; Jung-Hwa Han; Dae-Hwan Nam; Geun-Young Kim; Jae Hyang Lim; Jae-Ryong Kim; Chang-Hoon Woo
Journal:  Sci Rep       Date:  2018-10-11       Impact factor: 4.379

5.  PR3 and elastase alter PAR1 signaling and trigger vWF release via a calcium-independent mechanism from glomerular endothelial cells.

Authors:  Samantha P Tull; Anne Bevins; Sahithi Jyothsna Kuravi; Simon C Satchell; Bahjat Al-Ani; Stephen P Young; Lorraine Harper; Julie M Williams; George Ed Rainger; Caroline O S Savage
Journal:  PLoS One       Date:  2012-08-29       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.